One Year of Long-Acting Cabotegravir and Rilpivirine in People With Human Immunodeficiency Virus and Long Exposure to Antiretroviral Therapy: Data From the SCohoLART Study
Camilla Muccini(Vita-Salute San Raffaele University), Antonella Castagna(Vita-Salute San Raffaele University), Riccardo Lolatto(Vita-Salute San Raffaele University), Martina Bottanelli(Vita-Salute San Raffaele University), Diana Canetti(Vita-Salute San Raffaele University), Vincenzo Spagnuolo(Vita-Salute San Raffaele University), Sabrina Bagaglio(Vita-Salute San Raffaele University), Caterina Candela(Vita-Salute San Raffaele University), Silvia Nozza(IRCCS Ospedale San Raffaele), Nicola Gianotti(Vita-Salute San Raffaele University), Sara Diotallevi(Vita-Salute San Raffaele University), Victoria Gordo Perez(Vita-Salute San Raffaele University), Tommaso Clemente(Vita-Salute San Raffaele University)
Cited by 20
Related Papers
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency
|Critical Care and Resuscitation|2020|229
Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series
|The Lancet|2022|149
Mpox in people with past infection or a complete vaccination course: a global case series
|The Lancet Infectious Diseases|2023|141